The 22nd Annual Health Care Systems Research Network (HCSRN) Conference took place on April 13-16, 2016 in Atlanta, GA. The theme for this year’s conference was Advancing Population Health: New Models and the Role of Research. Three notable points that particularly highlighted this theme include: (1) growth of the HCSRN to include new sites that are not traditional integrated delivery systems, such as Catholic Health Initiatives, which covers a big geographic area but does not offer insurance products; (2) a call to do a better job en
The Society of Behavioral Medicine Annual Meeting took place in Washington, DC on March 30-April 2, 2016. The meeting covered a broad range of topics germane to behavioral medicine with sessions addressing cutting-edge research on health behaviors and behavior change, patient engagement and communication, management of chronic conditions, and population health and health disparities. Within these content areas, two themes were consistently addressed: 1. precision medicine and the role of behavioral science and 2.
The SEER PI meeting was held on March 16-17 in Albuquerque, NM and was sponsored by the New Mexico Tumor Registry. The meeting began with presentations by the NM tumor registry staff highlighting the unique characteristics of the region (e.g., racial/ethnic diversity, 5th largest state but 36th most populated) and summarizing current research projects, many of which are health disparities- related.
The NCI/ASCO teams in cancer care delivery initiative is focused on creating groups of clinicians and team scientists who work together to identify gaps and ways to improve clinical problems that involve clinical teams. Last spring, groups were formed that identified a specific population and set of challenges in teamwork and then met to discuss these topics in August. Groups then began drafting manuscripts for submission to a special issue in the Journal of Oncology Practice.
Last November the NIH issued a Notice clarifying the types of economics research that the agency will fund. Our OBSSR colleagues wrote an informative blog about the Notice in December. Although we in HDRP have received few questions about this notice, I thought it would be useful to provide some basic suggestions.
The “How Do We Assess Quality in the Age of Precision Medicine?” session at the ASCO Quality Symposium on February 26, 2016, provided a nice overview of the challenges physicians and delivery systems are encountering as precision cancer approaches move from the lab and clinical trials into community use.
In the past few weeks I have visited with faculty, fellows, and students at several local universities and have talked with peer reviewers attending a recent NIH study section. A number of people have shared with me their perception that NCI no longer funds R21. Hopefully this blog will clarify the situation.
I recently attended a course at the Harvard Business School called Strategy for Health Care Delivery , which is based on this text. The main thrust of the course and book is that health care delivery will improve only if we focus on what has value for the patient and design the system accordingly. Such a system would have six components:
Two studies published in December 2015 using data from the Medical Expenditure Panel Survey highlight the financial hardships and economic burden associated with cancer in the United States. The first study led by Robin Yabroff (formerly of HDRP) and published in the Journal of Clinical Oncology, looks at material financial hardship – measured by borrowing money/going into debt, filing for bankruptcy, being unable to cover costs of medical care
Last Wednesday, January 6, 2016, I had an opportunity to attend a presentation about NIH’s work with IBM’s Watson. Several groups at NIH have been exploring how Watson might benefit our operations and serve our intramural and extramural research communities. The presentation featured work that Mike Lauer, who is Deputy Director for Extramural Research, has been involved